FORAMINIFERA-DERIVED BONE GRAFT MATERIAL
20220249736 · 2022-08-11
Assignee
Inventors
Cpc classification
A61L2430/02
HUMAN NECESSITIES
A61L27/3637
HUMAN NECESSITIES
A61L27/3691
HUMAN NECESSITIES
A61L27/3604
HUMAN NECESSITIES
C01B25/32
CHEMISTRY; METALLURGY
A61F2002/2835
HUMAN NECESSITIES
A61L27/3687
HUMAN NECESSITIES
International classification
A61L27/36
HUMAN NECESSITIES
Abstract
The present disclosure relates to a foraminifera-derived bone graft material. A foraminifera-derived bone graft material according to an aspect of the present disclosure has remarkable abilities in terms of cell proliferation, cell adhesion, and osteoblast differentiation, and includes a structure that can support newly formed bones. Accordingly, the foraminifera-derived bone graft material may be effectively utilized as a bone graft material.
Claims
1. A bone graft material comprising hydroxyapatite, wherein the hydroxyapatite comprises a plurality of chambers separated by partition walls, and the partition walls comprise a plurality of pores.
2. The bone graft material of claim 1, wherein the hydroxyapatite is derived from foraminifera.
3. The bone graft material of claim 2, wherein the foraminifera is Baculogypsina sphaerulata, Baculogypsina bonarellii, Baculogypsina gallowayi, Baculogypsina lenticulate, Baculogypsina meneghinii, Baculogypsina saoneki, or Baculogypsina sphaerica.
4. The bone graft material of claim 1, wherein a plurality of the hydroxyapatite comprises particles, and the size of the particles is 100 um to 4,000 um.
5. The bone graft material of claim 1, wherein the chamber has a diameter in a range of 10 um to 80 um, the partition wall has a thickness in a range of 5 um to 15 um, or the pore has a size in a range of 0.1 um to 3 um.
6. The bone graft material of claim 1, wherein the bone graft material has 20,000 to 100,000 uniform chambers per 1 cm.sup.2 of the hydroxyapatite surface.
7. The bone graft material of claim 1, wherein the particle of the hydroxyapatite comprises 0.5 weight % to 10 weight % of magnesium ions, 0.2 weight % to 10 weight % of silicon ions, or 0.1 weight % to 5 weight % of strontium ions.
8. The bone graft material of claim 1, wherein the hydroxyapatite is prepared by performing a hydrothermal reaction on a pretreated exoskeleton of foraminifera at 30° C. to 600° C. for 2 hours to 40 hours, or by treating a pretreated exoskeleton of foraminifera with a microwave in a wavelength range of 300 MHz to 300 GHz in an amount of 100 to 1500 W for 0.5 minute to 48 hours.
9. The bone graft material of claim 1, wherein the bone graft material is for treating a bone defect.
10. A method of preparing the bone graft material of claim 1, the method comprising: pretreating foraminifera, and preparing hydroxyapatite by performing a hydrothermal reaction on the pretreated exoskeleton of foraminifera at 30° C. to 600° C. for 2 hours to 40 hours, or by treating the pretreated exoskeleton of foraminifera with a microwave in a wavelength range of 300 MHz to 300 GHz in an amount of 100 to 1500 W for 0.5 minute to 48 hours; and sintering the hydroxyapatite.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
MODE OF DISCLOSURE
[0059] Hereinafter, the present disclosure will be described in detail with reference to Examples below. However, these Examples are provided for illustrative purposes only, and the scope of the present disclosure is not limited thereto.
REFERENCE EXAMPLE 1
Cell Culture
[0060] The biocompatibility of foraminifera-derived hydroxyapatite (HAp) (also, referred to as foraminifera-HAp) was evaluated by using human mesenchymal stem cells (hMSCs). In detail, cells were cultured under conditions of 5% CO.sub.2 and 37° C. in a-MEM (Gibco-BRL, MD, Gaithersburg, Md.) supplemented with 10% fetal bovine serum (FBS; Gibco-BRL), wherein the cells subcultured from passage 4 to passage 6 were used for in vitro experiments.
[0061] To induce osteoblasts differentiation, the cells were cultured in a medium supplemented with an osteogenic stimulator (0.1 mM of dexamethasone, 0.1 M of 6-glycerophosphate, and 50 μg/mL of ascorbic acid). All compounds used in the medium supplemented with the osteogenic stimulator were cell culture-grade reagents (Sigma Aldrich, St. Louis, Mo., USA). A normal growth medium and the medium supplemented with the osteogenic stimulator were replaced with fresh media every 2 days during the experiments.
[0062] Before the cell culture experiments, HAp particles were first sterilized with 70% alcohol and washed with a phosphate buffer solution (PBS) three times for 10 minutes. After the sterilization, 20 mg of the sterilized pure HAp particles and foraminifera-derived HAp particles were added to a 48-well culture plate. The cells were seeded (at a concentration of 5×10.sup.4 cells/well) and cultured for 2 hours so that the initial cells were attached to each HAp particle. The HAp particles to which the cells were attached were transferred to a new culture plate, and then cultured for in vitro experiments.
REFERENCE EXAMPLE 2
Cell Proliferation
[0063] The cell proliferation was evaluated according to mitochondrial activity-based analysis using CellTiter96® Aqueous One solution (MTS assay, Invitrogen, Carlsbad, Calif., USA). As described above, the hMSCs were seeded and cultured for 1 day, 3 days, 6 days, 9 days, and 12 days. At a predetermined point, 50 μL of a CellTiter96® reagent solution was mixed with 250 μL of the normal medium, and the mixture was added to each well. After 4 hours of the cell culture, the supernatant was collected to measure absorbance at 490 nm by using an ELISA plate reader (SpectraMAX M3; Molecular Devices, Sunnyvale, Calif.).
REFERENCE EXAMPLE 3
Cell Viability and Cytotoxicity
[0064] The cell viability and cytotoxicity were evaluated according to fluorescence staining by using Live/Dead® and a viability/cytotoxicity kit (Invitrogen, Carlsbad, Calif., USA). According to the preparation protocol, the cultured HAp particles were washed with a PBS for 30 minutes. Subsequently, the cells were stained by using calcein acetoxymethyl ester (Calcein AM) and ethidium homodimer-1(EthD-1) of the kit, and then observed with an inverted fluorescence microscope (DM IL LED Flu( ) Leica Microsystems, Wetzlar, Germany).
REFERENCE EXAMPLE 4
In Vitro Evaluation of Cell Adhesion and Cell Infiltration
[0065] To observe the cell adhesion on the surface and the cell infiltration to each HAp particle, the cells were cultured for 5 days. A specimen was washed with a PBS, fixed in 2.5% glutaraldehyde solution at 4° C. for 2 hours, and post-fixed with 0.1% osmium tetroxide solution. Next, the specimen was dehydrated via graded ethanol series (30%, 50%, 75%, 85%, 95%, and 100%, each for 10 minutes). Then, the resulting specimen was sputter-coated with gold, and then observed with an electronic microscope (EM; EM-30). To observe the cell infiltration, the HAp particles were sliced with a sharp lancet to expose cross sections of the surface, followed by SEM analysis.
REFERENCE EXAMPLE 5
Measurement of Alkaline Phosphatase (ALP) Activity
[0066] The osteoblast differentiation was evaluated by ALP activity analysis. The ALP activity analysis was performed by using p-nitrophenylphosphate (p-NPP) as a substrate. In detail, the hMSCs were seeded on the particles, and then cultured in the medium supplemented with the osteogenic stimulator. After 5 days of the cell culture, adhesive cells were lysed by sonication in 1% Triton X-100/PBS solution under an icebox condition. To remove the particles and residues, the sample was centrifuged at 4° C. at a speed of 12,000 rpm. The supernatant was used for the ALP activity analysis and the protein concentration analysis. In the present study, the ALP activity was normalized to total protein contents.
reference example 6
Real-Time Polymerase Chain Reaction
[0067] To measure the osteoblast differentiation of the hMSCs cultured on the HAp particles, several osteogenesis marker genes, such as ALP, collagen type Iα1 (CoI1αI), osteocalcin (OCN), and bone sialoprotein (BSP), were measured by quantitative real-time polymerase chain reaction (RPCR). After the cells were cultured for 7 days in the medium supplemented with the osteogenic stimulator, total mRNAs were isolated from the cells, and cDNAs were transcribed with a reverse transcriptase (Invitrogen) and oligo (dT) primers. Then, the cDNAs were amplified with TaqMan Universal PCR Master mix(Applied Biosystem) and primers and TaqMan probe sets for ALP (Hs01029144_m1), Colla) (Hs00164004_m1), OCN (Hs01587814_g1), BSP (Hs00173720_m1), and 18S (Hsscience). All TaqMan PCRs were performed by using a StepOne Plus RPCR system (Applied Biosystems, Foster City, Calif., USA), and 18S rRNA gene was co-amplified as an internal standard.
REFERENCE EXAMPLE 7
Animal Model
[0068] 4 adult male New Zealand white rabbits (age >3 months or more, 2.5 kg to 3.0 kg) were anesthetized with intramuscular doses of ketamine (35 mg/kg; Yuhan Corporation, Seoul) and xylazine (5 mg/kg; Bayer Korea, Seoul). Then, 2% lidocaine solution was used for local anesthesia. After tissue excision, three isolated circular cranial defects were made by using trephine with an outer diameter of 6 mm. One defect was used as a control group, another defect was filled with pure HAp particles, and the other defect was filled with foraminifera-derived HAp particles. The healing process was observed 8 weeks after the graft, and the defects and the surrounding bones thereof were incised from host bones. Then, before performing further analysis, the specimen was removed and placed in a fixing solution (phosphate buffered 4% paraformaldehyde solution, pH 7.2) at 4° C. for 7 days.
REFERENCE EXAMPLE 8
Bone Analysis by Micro-CT
[0069] The newly formed bones were evaluated pathologically by micro-CT (Sky-Scan 1172TM, Skyscan, Kontich, Belgium). At the 8th week after the graft, the sample was analyzed by using an aluminum filter (0.5 mm) with X-ray set at a voltage of 60 kV and a current of 167 pA. Based on the micro-CT results, the qualitative images of the defects were observed with 3D reconstruction images based on a 3D software (CTVol, Skyscan), and the percent bone volume (BV) was calculated as follows by using an image analysis software (CT-analyzer TM, Skyscan).
BV(%)=(volume of new bones)-(volume of remaining graft material)/total defect volume
REFERENCE EXAMPLE 9
Histological Analysis
[0070] The histological analysis was performed at the 8th week after the graft. The fixed specimen of a rat cranium was treated with 8% formic acid/8% HCl to remove calcium deposit, and then dehydrated with graded alcohol series (70% to 100%). Finally, the specimen was placed in paraffin. Each specimen was cut into 5 pm sections by using a rotary microtone (HM 325™, Microm, Walldorf, Germany). Five sections from the center of each sample were stained with hematoxylin-eosin (HE) and Goldner's masson trichromand (MT). Then, the samples were randomly selected, and the formation of new bones was observed under a microscope (DMR, Leica, Nussloch, Germany).
REFERENCE EXAMPLE 10
Statistical Analysis
[0071] The numerical values are expressed as mean ±standard deviation (SD), and the statistical analysis was performed by one-way analysis of variance (ANOVA). Then, the Dunnett's post-hoc test was performed by using GraphPad Prism version 5.3 (GraphPad Software, SanDiego, Calif., USA), wherein P<0.05 was considered statistically significant.
EXAMPLES
Preparation and Analysis of Hydroxyapatite Particles
[0072] 1. Preparation of Hydroxyapatite (HAp) Particles by Using Foraminifera
[0073] The hydroxyapatite by using foraminifera were prepared as follows.
[0074] First, foraminifer (Baculogypsina sphaerulata, Okinawa, Japan) was purchased in the market. To remove residual contaminants and organic ingredients, the sample was boiled with 4% sodium perchlorate (NaClO.sub.4) and washed with distilled water. In detail, the sample was added to an ammonium phosphate monobasic ((NH.sub.4)H.sub.2PO.sub.4) aqueous solution, wherein a molar ratio of Ca:P was 10:6.
[0075] Subsequently, the sample was added to a Teflon-lined stainless autoclave, and heated at 200° C. for 24 hours. The transformed sample was washed with boiling water, and dried at 60° C. Then, HAp particles were chopped with a lancet, and HAp particles having a diameter in a range of 200 pm to 500 pm were separated by filtration through a stainless mesh. Afterwards, the crystallization was performed on the separated particles by a sintering process. The sintering was performed in an electric furnace (Muffle Furnace, SH-FU-4MH), wherein, after the temperature was raised to 600° C. at a heating rate of 5° C./min, the same temperature was maintained for 2 hours. Afterwards, the temperature was raised again to 800° C. at a heating rate of 5° C./min, and the same temperature was maintained for 4 hours. Then, the temperature was lowered to room temperature, thereby completing the sintering progress.
[0076] Here, as a control group, HAp particles (pure HAp particles having a particle size in a range of 200 μm to 500 μm) that were stoichiometrically synthesized were obtained from Dio Implant Inc. (Busan, Korea) and used.
[0077] 2. Chemical and Morphological Characteristics
[0078] To analyze compositions of the foraminifera-derived HAp of Example 1, the X-ray diffraction analysis (XRD; D8, Bruker AXS, Karlsruhe, Germany) using CuKa radiation was performed under conditions of a scanning rate of 0.02°/minute, voltage of 50 kV, and currency of 30 mA in a range of 10° to 80°. The ionic compositions of the sample was evaluated by X-ray fluorescence (XRF, Bruker) spectroscopy. The microstructure and surface morphology of the foraminifer-derived HAp particles were observed under vacuum by using a scanning electron microscope (SEM; EM-30, COXEM, Daejeon, Korea).
[0079] The SEM images obtained by observation are shown in
TABLE-US-00001 TABLE 1 Element Amount (%) Mg 2.98% Si 1.53% to 2.5% Sr 0.52% to 1.11%
[0080]
[0081]
[0082] As shown in
[0083] In addition, as shown in
[0084] As shown in
EXPERIMENTAL EXAMPLE 1
Cytotoxicity Measurement
[0085] To evaluate cytotoxicity of the foraminifera-derived HAp particles, the live/dead staining analysis was performed as described in Reference Examples, and results are shown in
[0086]
[0087] As shown in
EXPERIMENTAL EXAMPLE 2
Evaluation of Cell Proliferation
[0088] As described in Reference Examples, the cell proliferation of hMSCs in foraminifera-derived HAp was measured by using MTS mitochondrial activity-based assay. Results are shown in
[0089]
[0090] As shown in
EXPERIMENTAL EXAMPLE 3
Observation of Cell Adhesion and Cell Infiltration
[0091] By using the methods described in Reference Examples, the cell adhesion and infiltration of the hMSCs with respect to the pure HAp particles and the foraminifera-derived HAp particles were observed by using SEM on the 5th day of the cell culture, and results are shown in
[0092]
[0093] As shown in
EXPERIMENTAL EXAMPLE 4
Analysis of Osteoblast Differentiation Ability
[0094] To analyze the osteoblast differentiation ability, the ALP activity and qRT-PCR were performed as described in Reference Examples to detect osteoblast marker genes, such as ALP, Colla1, OCN, and BSP. Results are shown in
[0095]
[0096]
[0097] As shown in
[0098] Also, as shown in
[0099] These results suggest that hydroxyapatite according to an embodiment had significant osteoblast differentiation ability compared to pure hydroxyapatite.
EXPERIMENTAL EXAMPLE 5
Analysis of In Vivo Osteoanagenesis Ability
[0100] To evaluate in vivo osteoanagenesis ability of foraminifera-derived HAp prepared according to Examples above, the Micro-CT evaluation and histological evaluation were performed.
[0101] In detail, as described in Reference Examples, 3D micro-CT images were obtained at the 8th week after the graft, and results are shown in
[0102]
[0103]
[0104]
[0105] As shown in
[0106] Also, as shown in
[0107] As shown in